(Fox News) – A vaccine undergoing testing at the Mayo Clinic has reportedly removed cancer cells in a breast cancer patient. Florida resident Lee Mercker became the first patient to participate in a clinical trial for a new vaccine after being diagnosed in March with early-stages of the disease. She told First Coast News she had “DCIS stage zero” breast cancer, meaning the cancer cells had not yet spread. She was left with three
options — have a lumpectomy where the cancer cells are removed, undergo a mastectomy where the breasts are removed, or join a clinical trial for a potentially life-saving vaccine to kill the cells and prevent them from coming back. “I signed on the dotted line that day,” Mercker said of the 12-week trial at the clinics Jacksonville campus. “It’s supposed to stimulate a patient’s own immune response so that the immune cells like t-cells would go in and attack the cancer,” said Dr. Saranya Chumsri, an oncologist at the world-renowned medical center. READ MORE
